Drug Database
Back to search

Poland· PL-100457177

Fingolimod Mylan

A fingolimod product containing fingolimodum, registered in Poland by Mylan Pharmaceuticals Ltd. The same ATC class is registered in 3 of our 19 countries.

ATC L04AA27

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFingolimod MylanATCL04AA27REGISTER NO.PL-100457177PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fingolimodumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fingolimod is registered in 3 of 19 countries.

Countries holding a registration under ATC L04AA27 (fingolimod), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search fingolimod products by name

Fingolimod · ATC L04AA27

3 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Fingolimodum
Manufacturer
Mylan Pharmaceuticals Ltd
Country
Poland (PL)
ATC code
L04AA27
ATC class
Fingolimod
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

584 interactions on record for fingolimod.

Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fingolimod against other medicinesHow interaction checks work

Fingolimod · interactions on record

584 records

  • 503 severe
  • 77 moderate
  • 4 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fingolimod in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fingolimod products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Areleptan, Chantico
  • Belgium · Fingolimod Ab, Fingolimod Eg
  • Bulgaria · Chantico, Inzolfi
  • Cyprus · Fingolimod Adelco, Fingolimod Remedica
  • Czechia · Areleptan, Bonaxon
  • Germany · Fingod, Fingolimod 123 Acurae Pharma
  • Denmark · Areleptan, Bonaxon
  • Estonia · Chantico, Efigalo
  • Spain · Fingolimod, Fingolimod Aurovitas
  • Finland · Fingolimod, Fingolimod Avansor
  • France · Fingolimod Arrow, Fingolimod Benta
  • United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
  • Greece · Fingolimod Adelco, Fingolimod Medochemie
  • Croatia · Areleptan, Arlesias
  • Hungary · Bonaxon, Chantico
  • Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
  • Iceland · Fingolimod, Fingolimod Accord
  • Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
  • Liechtenstein · Fingolimod Accord, Fingolimod Mylan
  • Lithuania · Chantico, Efigalo
  • Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
  • Latvia · Bonaxon, Chantico
  • Malta · Fingolimod Denk, Fingolimod Remedica
  • Netherlands · Chantico, Fenoxa
  • Norway · Areleptan, Fingolimod Accord
  • Portugal · Bluesar, Fingolimod Bluefish
  • Romania · Fingolimod Dr. Reddys, Fingolimod Msn
  • Sweden · Areleptan, Fingolimod Amarox
  • Slovenia · Areleptan, Arlesias
  • Slovakia · Areleptan, Bonaxon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9ea5ae85-deec-427b-9b89-200f83f5616f
GET /v1/drugs/9ea5ae85-deec-427b-9b89-200f83f5616f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "0,5 mg",
  "packaging": "Rpz ¦ EU/1/21/1573/002 ¦ 143993\n28 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/001 ¦ 143994\n7 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/019 ¦ 143995\n30 kaps.\nRpz ¦ EU/1/21/1573/024 ¦ 143996\n84 kaps.\nRpz ¦ EU/1/21/1573/020 ¦ 143997\n84 kaps.\nRpz ¦ EU/1/21/1573/012 ¦ 143998\n90 kaps.\nRpz ¦ EU/1/21/1573/010 ¦ 143999\n28 kaps.\nRpz ¦ EU/1/21/1573/021 ¦ 144000\n98 kaps.\nRpz ¦ EU/1/21/1573/023 ¦ 144001\n28 kaps.\nRpz ¦ EU/1/21/1573/011 ¦ 144002\n84 kaps.\nRpz ¦ EU/1/21/1573/014 ¦ 144003\n7 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/006 ¦ 144004\n30 kaps.\nRpz ¦ EU/1/21/1573/013 ¦ 144005\n100 kaps.\nRpz ¦ EU/1/21/1573/016 ¦ 144006\n90 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/007 ¦ 144007\n84 kaps.\nRpz ¦ EU/1/21/1573/004 ¦ 144008\n98 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/017 ¦ 144009\n98 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/005 ¦ 144010\n28 kaps.\nRpz ¦ EU/1/21/1573/003 ¦ 144011\n90 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/009 ¦ 144012\n84 kaps. (3 x 28)\nRpz ¦ EU/1/21/1573/022 ¦ 144013\n84 kaps. (3 x 28)\nRpz ¦ EU/1/21/1573/008 ¦ 144014\n98 kaps.\nRpz ¦ EU/1/21/1573/015 ¦ 144015\n28 kaps. w blistrze perforowanym\nRpz ¦ EU/1/21/1573/018 ¦ 144016\n28 kaps.",
  "substance": "Fingolimodum 0.5 mg",
  "common_name": "Fingolimodum",
  "pl_product_id": "100457177",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about fingolimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console